Skip to main content
An official website of the United States government

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
LeeVan, Elyse, M.D., M.P.H.
elyse.leevan@nih.gov
240-276-7314
5E110 Program Officer | Early Detection
McCarty, Larae
larae.mccarty@nih.gov
240-276-5777
5E322 Program Specialist | Community Oncology and Prevention Trials
Early Detection
Miller, Eric, Ph.D.
eric.miller2@nih.gov
240-276-5336
5E212 Program Officer | Early Detection
Ong, Mary Jane
maryjane.ong@nih.gov
240-858-3296
5E120 Nurse Consultant | Early Detection
Pinsky, Paul, Ph.D.
paul.pinsky@nih.gov
240-276-7014
5E108 Chief | Early Detection
Saxena, Neeraj, Ph.D.
neeraj.saxena@nih.gov
240-276-6302
5E218 Program Officer | Early Detection
Zhu, Claire, Ph.D.
claire.zhu@nih.gov
240-276-7013
5E106 Program Officer | Early Detection

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Elmore, Joann G

University Of California Los Angeles
United States

Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance 1R01CA288824-01A1 Claire Zhu, Ph.D.
Elswick, Ronald K

Virginia Commonwealth University
United States

A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer 5R01CA286799-03 Asad Umar, D.V.M., Ph.D.
Esserman, Laura J

University Of California, San Francisco
United States

Extending the Diversity, Reach, and Generalizability of the WISDOM Study 5R01CA237533-05 Claire Zhu, Ph.D.
Esserman, Laura J

University Of California, San Francisco
United States

WISDOM: A platform to optimize subtype-specific screening and prevention 5P01CA281826-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fabian, Carol J.

University Of Kansas Medical Center
United States

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer 5R01CA249437-05 Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F

University Of Tx Md Anderson Can Ctr
United States

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 5U01CA282216-03 Claire Zhu, Ph.D.
Faller, Bryan

Decatur Memorial Hospital
United States

Heartland Cancer Research NCORP 3UG1CA189830-11S1 Vanessa A. White, M.P.H.
Farrar, Christian T

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 4R01CA273010-04 Guillermo Marquez, Ph.D.
Feng, Ziding

Fred Hutchinson Cancer Center
United States

Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 5U24CA230144-09 Guillermo Marquez, Ph.D.
Fiol, Guilherme Del

University Of Utah
United States

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 5U24CA274582-03 Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L.

University Of Illinois At Chicago
United States

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk 5R01CA250390-05 Young Kim, Ph.D.
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flowers, Lisa C.

Emory University
United States

Screening Strategies Among High-Risk Populations for Anal Cancer 5R01CA285198-03 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flowers, Lisa C.

Emory University
United States

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) 5UG1CA284884-03 Maria Silvina Frech, Ph.D., M.S.
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 5R01CA285925-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.